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Infusing arginine vasopressin (AVP) in vasodilatory shock usually decreases
cardiac output and thus systemic oxygen transport. It is still a matter of debate
whether this vasoconstriction impedes visceral organ blood flow and thereby
causes organ dysfunction and injury. Therefore, we tested the hypothesis whether
low-dose AVP is safe with respect to liver, kidney, and heart function and organ
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